0.00015919923736906 0.000142993326978125 -0.000111217032093957 9.53288846521435E-05 0.00167270416269471 0.00206545916746118 0.000158881474420119 0.00308230060374969
Sign Up Today X
Thanks for submitting the form.
Stockreport

The 9 top biotech startups from Disrupt Startup Battlefield [TechCrunch]

Alphabet Inc. - Class C Capital Stock (GOOG)  More Company Research Source: TechCrunch
Last alphabet inc. - class c capital stock earnings: 4/28 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: abc.xyz/investor
We whittle those applications down to the top 200 contenders , and of them, the top 20 compete on the big stage to become the winner, taking home the Startup Battlefield Cup and a cash prize of $100,000. But the remaining 180 startups all blew us away as well in their respective categories and compete in their own pitch competition. Here is the full list of the biotech and pharma Startup Battlefield 200 selectees, along with a note on why they landed in the competition. CasNx What it does: CasNx has invented a new kind of antivirus treatment for organs from organ donors. Why it's noteworthy: The startup has invented a gene-editing CRISPR kit that eliminates viruses and installs “universal donor” markers while the organ is being preserved outside the body. Chipiron What it does: Chipiron is building a light and inexpensive, open full-body MRI machine intended to make MRI cancer diagnostics more widely available. Why it's noteworthy: The medical MRI machine is being built [Read more]
IMPACT SNAPSHOT EVENT TIME: GOOG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GOOG alerts
from News Quantified
GOOG
NEWS
GOOG
Earnings
GOOG
Analyst Actions
GOOG
SEC Filings
Stockreport

The 9 top biotech startups from Disrupt Startup Battlefield [TechCrunch]

Alphabet Inc. - Class C Capital Stock  (GOOG) 
More Company Research Source: TechCrunch
Last alphabet inc. - class c capital stock earnings: 4/28 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: abc.xyz/investor
We whittle those applications down to the top 200 contenders , and of them, the top 20 compete on the big stage to become the winner, taking home the Startup Battlefield Cup and a cash prize of $100,000. But the remaining 180 startups all blew us away as well in their respective categories and compete in their own pitch competition. Here is the full list of the biotech and pharma Startup Battlefield 200 selectees, along with a note on why they landed in the competition. CasNx What it does: CasNx has invented a new kind of antivirus treatment for organs from organ donors. Why it's noteworthy: The startup has invented a gene-editing CRISPR kit that eliminates viruses and installs “universal donor” markers while the organ is being preserved outside the body. Chipiron What it does: Chipiron is building a light and inexpensive, open full-body MRI machine intended to make MRI cancer diagnostics more widely available. Why it's noteworthy: The medical MRI machine is being built [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GOOG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS